Terns Pharmaceuticals, Inc. (TERN) Debt-to-equity % [USD] 2021 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Terns Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2024.
Terns Pharmaceuticals, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 5.08 %, a 11.7% increase year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	5.08	+0.53	+11.7%	Mar 31, 2024
Q4 2023	5.17	+0.53	+11.4%	Dec 31, 2023
Q3 2023	4.78	-0.34	-6.64%	Sep 30, 2023
Q2 2023	4.71	-0.32	-6.36%	Jun 30, 2023
Q1 2023	4.54	-0.01	-0.22%	Mar 31, 2023
Q4 2022	4.63	+0.17	+3.81%	Dec 31, 2022
Q3 2022	5.12	-5.99	-53.9%	Sep 30, 2022
Q2 2022	5.03			Jun 30, 2022
Q1 2022	4.55			Mar 31, 2022
Q4 2021	4.46			Dec 31, 2021
Q3 2021	11.1			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.